Salem Radio Network News Thursday, October 21, 2021

Health

Pfizer begins study for COVID-19 antiviral drug

(Reuters) – Pfizer Inc said on Monday it has started a mid-to-late-stage study testing its investigational oral antiviral drug, to be co-administered with HIV drug ritonavir, for the prevention of COVID-19 infection.

(Reporting by Manojna Maddipatla in Bengaluru; Editing by Krishna Chandra Eluri)

Previous
Next

Editorial Cartoons

View More »

Steve Breen
Sat, Oct 16, 2021

X CLOSE